Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewChildhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera...
Marina Salmón, Head of Project Evaluation at the Scientific Foundation of the Spanish Association Against Cancer, a partner of AseBio, analyzes the situation on International Childhood Cancer Day.
-
Press releaseChildhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera...
In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more challenging and requiring cooperation among multiple centers, including internationally
-
NewGyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute ...
The study has been initiated at Hospital La Fe in Valencia and Hospital Clínic Barcelona, two internationally recognized refence centers for acute leukemias and advanced therapies.
-
NewORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer...
Based in New Jersey (USA), to lead ORYZON’s CNS clinical development.
-
NewMore Women in Science: Biotechnology as a Driving Force to Close the Gender Gap
AseBio and the Biotech Platform are launching the fourth edition of “A Day with a Biotech Woman”, enabling young women—the emerging talent of today—to experience and closely follow the work of a
-
Press release
More Women in Science: Biotechnology as a Driving Force to Close the Gender Gap
Women remain underrepresented in key sectors of the Fourth Industrial Revolution, accounting for only 22% of professionals in artificial intelligence, 28% in engineering, and 40% in computer science
-
NewORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadade...
The study, led by Yale University, explore the combination with atezolizumab and radiation therapy.
-
NewSpain can turn alternative proteins into a driver of competitiveness if it accelerates R&D...
Two recent reports map Spain’s ecosystem and quantify the economic potential of alternative proteins: up to €10 billion annually and 34,000 jobs in Spain by 2040 under a scenario of moderate support
-
-
NewGENESIS Biomed closes 2025 with record growth and greater impact on the biomedical ecosyst...
GENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).
-
EventWebinar: Metabolic Instability of Peptide Therapeutics: Mechanisms, Analytical Strategies,...
11am EST / 4pm GMT (UK) / 5pm CET (EU-Central).
-
EventWebinar: Accelerating Clinical Entry for Poorly Soluble Molecules
11am EST / 4pm GMT (UK) / 5pm CET (EU-Central).
-
CompanyELE Biotech
-
NewViva In Vitro appoints Professor Ignacio Martín-Loeches to its Medical Advisory Board, str...
Dr Ignacio Martín-Loeches joins Viva In Vitro Diagnostics as an advisor to its Medical Advisory Board, further strengthening a committee that already includes Dr Ricard Ferrer Roca (Vall d’Hebron
-
NewBCN HEALTH publishes a study highlighting the substantial productivity losses associated w...
Despite advances in oncology care, the persistently poor prognosis of pancreatic cancer and rising mortality rates have led to a sustained increase in productivity losses, particularly among the
-
NewThe need to promote entrepreneurship among young people
Youth entrepreneurship emerges as a natural response to a changing environment, where young people seek to transform ideas into real solutions and face social challenges with creativity, initiative
-
CompanyMOLEFY PHARMA
-
NewBiotechnology in the fight against cancer: from smart vectors to protein disorder as a the...
Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life
-
Press release
Biotechnology in the fight against cancer: from smart vectors to protein disorder as a the...
Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life
-
NewWhen genetics does not change, but science does. The challenge of keeping genetic health i...
A person's genetics do not change throughout their life. What does change, and does so constantly, is the scientific knowledge that allows us to interpret that information. This difference is forcing
-
NewORYZON strengthens patent portfolio for vafidemstat with new Decision to Grant in Japan
For the treatment of aggression and social withdrawal.